
He
joins Luke Akard, MD; Michael Dugan, MD; and James Thompson, MD, in providing
care to patients undergoing autologous and allogeneic stem cell
transplantation, as well as patients with hematological malignances, including
acute leukemia, myeloma and lymphoma. 
Edwards brings to IBMT extensive clinical and laboratory experience in
hematology, oncology and stem cell therapy. 
“For
more than 25 years IBMT has provided patient-focused care along with
cutting-edge clinical trials for those in need of hematopoietic stem cell
transplantation or fighting blood cancer,” said Akard, IBMT co-director. “The
addition of a caring physician like Dr. Edwards, who also brings a wealth of
expertise in stem cell processing and all aspects of clinical trials, will
allow us to continue to stay at the forefront of advanced care with the patient
and family as our primary focus.” 
Board-certified in Pediatric Hematology/Oncology,
Edwards comes to IBMT from CTI Clinical Trial and Consulting Services in Cincinnati 
He later served as president,
chief operating office and chief medical officer for Lifeforce Cryobanks, a
National Marrow Donor program-approved umbilical cord blood.
A member of the International
Society for Cellular Therapy and the American Society for Blood and Marrow
Transplant, he earned his medical degree from the University 
of Florida  and trained in pediatrics
as well as pediatric immunology and hematology/oncology at the University  of California ,
San Francisco 
He performed additional
fellowship training in BMT and pediatric hematology/oncology at the University  of Florida 
before joining the faculty at Vanderbilt 
 University 
Edwards held appointments as an
instructor at the University of Florida  and University  of California ,
San Francisco  ,as well as being on the adjunct
faculty at Duke  University 
and the University 
 of Central Florida 
The IBMT
clinic is located in the Franciscan St. Francis Cancer Center, 8111 S. Emerson Ave. 
 
 
 
